Since he was 18, Rick Doblin has devoted himself to becoming a legal psychedelic psychotherapist. In 1986, he founded a nonprofit psychedelic pharmaceutical company -- the Multidisciplinary Association for Psychedelic Studies (MAPS) -- which he has grown from a one-man project to an international psychedelic pharmaceutical company.

Doblin's professional goal is to become a legally licensed psychedelic psychotherapist by developing legal contexts for the safe uses of psychedelics and marijuana as prescription medicines and also for personal growth, spirituality, and creativity. Today, MAPS is designing or sponsoring psychedelic psychotherapy drug development research in over a dozen countries and has raised more than $70 million in donations.

Doblin received his master's and Ph.D. in public policy from the Kennedy School of Government at Harvard University, and he was in the first group to be certified by Dr. Stanislav Grof as a Holotropic Breathwork practitioner.

Health, Healthcare, Futurism, Healthcare Policy, Fitness & Nutrition Experts, Nutrition, Mental Health, Business of Healthcare, Psychologists, Psychology, Psychological safety, Pharmaceutical, Science, Researcher, Research scientist, PTSD Veteran, TED, Business,